title: Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types.
abstract: BACKGROUND
  We address the ecological and evolutionary dynamics of human papillomavirus (HPV) that lead to the dichotomy between high-risk (HR) and low-risk (LR) types. We hypothesize that HPV faces an evolutionary tradeoff between persistence and per-contact transmission probability. High virion production enhances transmissibility but also provokes an immune response leading to clearance and limited persistence. Alternatively, low virion production increases persistence at the cost of diminished transmission probability per sexual contact. We propose that LR HPV types use the former strategy and that HR types use the latter. Sexual behaviors in a host population determine the success of each strategy.
  
  
  METHODS
  We develop an evolutionary model of HPV epidemiology, which includes host sexual behavior, and we find evolutionarily stable strategies of HPV.
  
  
  RESULTS
  A slow turnover of sexual partners favors HR HPV, whereas high frequency of partner turnover selects for LR. When both sexual behaviors exist as subcultures in a population, disruptive selection can result in the coevolution and ecological coexistence of both HR and LR HPV types.
  
  
  CONCLUSIONS
  Our results indicate that the elimination of HR HPV through vaccines may alter the evolutionary trajectory of the remaining types and promote evolution of new HR HPV types.
authors.affiliation: Department of Biological Sciences, University of Illinois at Chicago, IL 60607, USA. porlan1@uic.edu
authors.forename: Paul A
authors.initials: PA
authors.lastname: Orlando
authors.forename: Robert A
authors.initials: RA
authors.lastname: Gatenby
authors.forename: Anna R
authors.initials: AR
authors.lastname: Giuliano
authors.forename: Joel S
authors.initials: JS
authors.lastname: Brown
mesh_terms: D017753:Ecosystem; D019143:Evolution, Molecular; D006801:Humans; D008954:Models, Biological; D027383:Papillomaviridae; D030361:Papillomavirus Infections / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D053918:Papillomavirus Vaccines; D015995:Prevalence; D012307:Risk Factors; D012725:Sexual Behavior; D012747:Sexual Partners
chemical_list: D053918:Papillomavirus Vaccines
references.citation: Int J Cancer. 2006 Oct 1;119(7):1623-9
references.pmid: 16646070
references.citation: J Virol. 1996 May;70(5):3298-301
references.pmid: 8627814
references.citation: Clin Sci (Lond). 2006 May;110(5):525-41
references.pmid: 16597322
references.citation: Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78
references.pmid: 8876633
references.citation: Virology. 2004 Jun 20;324(1):17-27
references.pmid: 15183049
references.citation: Sex Transm Dis. 2001 Mar;28(3):125-30
references.pmid: 11289192
references.citation: Int J Cancer. 2011 Feb 15;128(4):879-86
references.pmid: 20473890
references.citation: J Sex Med. 2010 Oct;7 Suppl 5:277-90
references.pmid: 21029385
references.citation: J Sex Med. 2010 Oct;7 Suppl 5:291-304
references.pmid: 21029386
references.citation: J Natl Cancer Inst. 1995 Jun 7;87(11):796-802
references.pmid: 7791229
references.citation: J Obstet Gynaecol Res. 2000 Aug;26(4):253-7
references.pmid: 11049234
references.citation: Sex Transm Infect. 2004 Apr;80(2):118-20
references.pmid: 15054172
references.citation: Br J Vener Dis. 1971 Feb;47(1):1-13
references.pmid: 5550858
references.citation: Q Rev Biol. 1996 Mar;71(1):37-78
references.pmid: 8919665
references.citation: Proc Biol Sci. 1999 Feb 22;266(1417):397-404
references.pmid: 10097397
references.citation: APMIS. 2010 May;118(5):346-52
references.pmid: 20477809
references.citation: J Infect Dis. 2008 Sep 15;198(6):827-35
references.pmid: 18657037
references.citation: Epidemiology. 2002 Nov;13(6):631-9
references.pmid: 12410003
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Apr;16(4):709-15
references.pmid: 17416761
references.citation: Virology. 1992 Oct;190(2):587-96
references.pmid: 1325697
references.citation: Math Biosci. 2005 Sep;197(1):88-117
references.pmid: 16095627
references.citation: J Med Virol. 2003 Nov;71(3):440-5
references.pmid: 12966552
references.citation: J Virol. 2003 Oct;77(19):10186-201
references.pmid: 12970404
references.citation: J Infect Dis. 2010 Aug 15;202(3):436-44
references.pmid: 20557239